|
1
|
Barnes L, Eveson JW, Reichart P and
Sidransky D: World Health Organization Classification of Tumours.
Pathology and Genetics of Head and Neck Tumours. Lyon, France: IARC
Press; pp. 46–50. 2005
|
|
2
|
Jo VY, Mills SE, Stoler MH and Stelow EB:
Papillary squamous cell carcinoma of the head and neck: Frequent
association with human papillomavirus infection and invasive
carcinoma. Am J Surg Pathol. 33:1720–1724. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Benevolo M, Mottolese M, Marandino F,
Vocaturo G, Sindico R, Piperno G, Mariani L, Sperduti I, Canalini
P, Donnorso RP and Vocaturo A: Immunohistochemical expression of
p16(INK4a) is predictive of HR-HPV infection in cervical low-grade
lesions. Mod Pathol. 19:384–391. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lewis JS Jr, Thorstad WL, Chernock RD,
Haughey BH, Yip JH, Zhang Q and El-Mofty SK: p16 positive
oropharyngeal squamous cell carcinoma: An entity with a favorable
prognosis regardless of tumor HPV status. Am J Surg Pathol.
34:1088–1096. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mehrad M, Carpenter DH, Chernock RD, Wang
H, Ma XJ, Luo Y, Luo J, Lewis JS Jr and El-Mofty SK: Papillary
squamous cell carcinoma of the head and neck: Clinicopathologic and
molecular features with special reference to human papillomavirus.
Am J Surg Pathol. 37:1349–1356. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cai C, Chernock RD, Pittman ME, El-Mofty
SK, Thorstad WL and Lewis JS Jr: Keratinizing-type squamous cell
carcinoma of the oropharynx: p16 overexpression is associated with
positive high-risk HPV status and improved survival. Am J Surg
Pathol. 38:809–815. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Müeller-Pillasch F, Lacher U, Wallrapp C,
Micha A, Zimmerhackl F, Hameister H, Varga G, Friess H, Büchler M,
Beger HG, et al: Cloning of a gene highly overexpressed in cancer
coding for a novel KH-domain containing protein. Oncogene.
14:2729–2733. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mueller-Pillasch F, Pohl B, Wilda M,
Lacher U, Beil M, Wallrapp C, Hameister H, Knöchel W, Adler G and
Gress TM: Expression of the highly conserved RNA binding protein
KOC in embryogenesis. Mech Dev. 88:95–99. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nielsen FC, Nielsen J and Christiansen J:
A family of IGF-II mRNA binding proteins (IMP) involved in RNA
trafficking. Scand J Clin Lab Invest Suppl. 234:93–99. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Monk D, Bentley L, Beechey C, Hitchins M,
Peters J, Preece MA, Stanier P and Moore GE: Characterisation of
the growth regulating gene IMP3, a candidate for Silver-Russell
syndrome. J Med Genet. 39:575–581. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liao B, Hu Y, Herrick DJ and Brewer G: The
RNA-binding protein IMP-3 is a translational activator of
insulin-like growth factor II leader-3 mRNA during proliferation of
human K562 leukemia cells. J Biol Chem. 280:18517–18524. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vikesaa J, Hansen TV, Jønson L, Borup R,
Wewer UM, Christiansen J and Nielsen FC: RNA-binding IMPs promote
cell adhesion and invadopodia formation. EMBO J. 25:1456–1468.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hoffmann NE, Sheinin Y, Lohse CM, Parker
AS, Leibovich BC, Jiang Z and Kwon ED: External validation of IMP3
expression as an independent prognostic marker for metastatic
progression and death for patients with clear cell renal cell
carcinoma. Cancer. 112:1471–1479. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jiang Z, Lohse CM, Chu PG, Wu CL, Woda BA,
Rock KL and Kwon ED: Oncofetal protein IMP3: A novel molecular
marker that predicts metastasis of papillary and chromophobe renal
cell carcinomas. Cancer. 112:2676–2682. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li C, Rock KL, Woda BA, Jiang Z, Fraire AE
and Dresser K: IMP3 is a novel biomarker for adenocarcinoma in situ
of the uterine cervix: An immunohistochemical study in comparison
with p16(INK4a) expression. Mod Pathol. 20:242–247. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li C, Zota V, Woda BA, Rock KL, Fraire AE,
Jiang Z, Lu D, Xu B, Dresser K, Lutman CV and Fischer AH:
Expression of a novel oncofetal mRNA-binding protein IMP3 in
endometrial carcinomas: Diagnostic significance and
clinicopathologic correlations. Mod Pathol. 20:1263–1268. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lu D, Vohra P, Chu PG, Woda B, Rock KL and
Jiang Z: An oncofetal protein IMP3: A new molecular marker for the
detection of esophageal adenocarcinoma and high-grade dysplasia. Am
J Surg Pathol. 33:521–525. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pryor JG, Bourne PA, Yang Q, Spaulding BO,
Scott GA and Xu H: IMP-3 is a novel progression marker in malignant
melanoma. Mod Pathol. 21:431–437. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pryor JG, Simon RA, Bourne PA, Spaulding
BO, Scott GA and Xu H: Merkel cell carcinoma expresses K homology
domain-containing protein overexpressed in cancer similar to other
high-grade neuroendocrine carcinomas. Hum Pathol. 40:238–243. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sitnikova L, Mendese G, Liu Q, Woda BA, Lu
D, Dresser K, Mohanty S, Rock KL and Jiang Z: IMP3 predicts
aggressive superficial urothelial carcinoma of the bladder. Clin
Cancer Res. 14:1701–1706. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu H, Bourne PA, Spaulding BO and Wang HL:
High-grade neuroendocrine carcinomas of the lung express K homology
domain containing protein overexpressed in cancer but carcinoid
tumors do not. Hum Pathol. 38:555–563. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Strehl JD, Hoegel J, Hornicek I, Hartmann
A and Riener MO: Immunohistochemical expression of IMP3 and p53 in
inflammatory lesions and neoplastic lesions of the gastric mucosa.
Int J Clin Exp Pathol. 7:2091–2101. 2014.PubMed/NCBI
|
|
23
|
Wachter DL, Kristiansen G, Soll C,
Hellerbrand C, Breuhahn K, Fritzsche F, Agaimy A, Hartmann A and
Riener MO: Insulin-like growth factor II mRNA-binding protein 3
(IMP3) expression in hepatocellular carcinoma. A
clinicopathological analysis with emphasis on diagnostic value.
Histopathology. 60:278–286. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wachter DL, Schlabrakowski A, Hoegel J,
Kristiansen G, Hartmann A and Riener MO: Diagnostic value of
immunohistochemical IMP3 expression in core needle biopsies of
pancreatic ductal adenocarcinoma. Am J Surg Pathol. 35:873–877.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yantiss RK, Woda BA, Fanger GR, Kalos M,
Whalen GF, Tada H, Andersen DK, Rock KL and Dresser K: KOC (K
homology domain containing protein overexpressed in cancer): A
novel molecular marker that distinguishes between benign and
malignant lesions of the pancreas. Am J Surg Pathol. 29:188–195.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao H, Mandich D, Cartun RW and Ligato S:
Expression of K homology domain containing protein overexpressed in
cancer in pancreatic FNA for diagnosing adenocarcinoma of pancreas.
Diagn Cytopathol. 35:700–704. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Riener MO, Fritzsche FR, Clavien PA,
Pestalozzi BC, Probst-Hensch N, Jochum W and Kristiansen G: IMP3
expression in lesions of the biliary tract: A marker for high-grade
dysplasia and an independent prognostic factor in bile duct
carcinomas. Hum Pathol. 40:1377–1383. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Walter O, Prasad M, Lu S, Quinlan RM,
Edmiston KL and Khan A: IMP3 is a novel biomarker for triple
negative invasive mammary carcinoma associated with a more
aggressive phenotype. Hum Pathol. 40:1528–1533. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lin CY, Chen ST, Jeng YM, Yeh CC, Chou HY,
Deng YT, Chang CC and Kuo MY: Insulin-like growth factor II
mRNA-binding protein 3 expression promotes tumor formation and
invasion and predicts poor prognosis in oral squamous cell
carcinoma. J Oral Pathol Med. 40:699–705. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li S, Cha J, Kim J, Kim KY, Kim HJ, Nam W
and Cha IH: Insulin-like growth factor II mRNA-binding protein 3: A
novel prognostic biomarker for oral squamous cell carcinoma. Head
Neck. 33:368–374. 2011.PubMed/NCBI
|
|
31
|
Kim KY, Li S, Cha JD, Zhang X and Cha IH:
Significance of molecular markers in survival prediction of oral
squamous cell carcinoma. Head Neck. 34:929–936. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li HG, Han JJ, Huang ZQ, Wang L, Chen WL
and Shen XM: IMP3 is a novel biomarker to predict metastasis and
prognosis of tongue squamous cell carcinoma. J Craniofac Surg.
22:2022–2025. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Clauditz TS, Wang CJ, Gontarewicz A,
Blessmann M, Tennstedt P, Borgmann K, Tribius S, Sauter G, Dalchow
C, Knecht R, et al: Expression of insulin-like growth factor II
mRNA-binding protein 3 in squamous cell carcinomas of the head and
neck. J Oral Pathol Med. 42:125–132. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen K, Cornejo KM, Ye W, Wu Q, Liang J
and Jiang Z: Oncofetal protein IMP3: A new diagnostic biomarker for
laryngeal carcinoma. Hum Pathol. 44:2126–2131. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Knör M, Tziridis K, Agaimy A, Zenk J and
Wendler O: Human Papillomavirus (HPV) Prevalence in Nasal and
Antrochoanal Polyps and association with clinical data. PLoS One.
10:e01417222015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ismerim AB, Ferreira SV, Lessa AM, Júnior
AS Pereira, Gurgel CA, Coutinho-Camillo CM, Soares FA, Vilas-Bôas
DS, Vidal MT and Santos JN: Insulin-like growth factor II messenger
RNA-binding protein 3 in Salivary Gland tumors. Appl
Immunohistochem Mol Morphol. 24:422–426. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wei Q, Fu B, Liu J, Xu J and Zhao T:
Combined detection of p16(INK4a) and IMP3 increase the concordance
rate between cervical cytologic and histologic diagnosis. Int J
Clin Exp Pathol. 6:1549–1557. 2013.PubMed/NCBI
|
|
38
|
Del Gobbo A, Bonoldi E, Cribiù FM,
Franceschetti I, Matinato C, Fiori S, Gianelli U and Bosari S:
Insulin-like growth factor II mRNA binding protein 3 (IMP3)
expression in cervical intraepithelial neoplasia and its
relationship with HIV-infection status. Sex Health. 12:22–26. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yoshitake Y, Fukuma D, Yuno A, Hirayama M,
Nakayama H, Tanaka T, Nagata M, Takamune Y, Kawahara K, Nakagawa Y,
et al: Phase II clinical trial of multiple peptide vaccination for
advanced head and neck cancer patients revealed induction of immune
responses and improved OS. Clin Cancer Res. 21:312–321. 2015.
View Article : Google Scholar : PubMed/NCBI
|
